[Inappropriate systemic therapy in severe atopic dermatitis-severe long-term damage]
{{output}}
The therapeutic options for treatment of severe cases of atopic dermatitis have been limited until recently, but fundamentally improved with the approval of the first biological dupilumab at the end of 2017. With the biological tralokinumab and the Janus kinas... ...
